Peptide crosslinking agent and crosslinked peptide which is crosslinked using said crosslinking agent
AssigneeKagoshima University
InventorsYuji ITO, Hiroshi NAKAYAMA, Md Abdur RAFIQUE
Life of this patent
Estimating the term…
Abstract
A crosslinking agent for a protein or a peptide is represented by the following formula (I). In the formula, A is a hydrogen atom, a C1 to 6 alkyl group optionally substituted with a phenyl group or a halogen atom, or a phenyl group.
Claims35
A crosslinking agent for a protein or a peptide, represented by the following formula (I):
- wherein A is a hydrogen atom, a C1 to 6 alkyl group optionally substituted with a phenyl group or a halogen atom, or a phenyl group.
A method for producing a protein(s) or a peptide(s) bound to a reactive functional group which is represented by the following formula:
- wherein A is a hydrogen atom, a C1 to 6 alkyl group optionally substituted with a phenyl group or a halogen atom, a phenyl group, or a C1 to 6 alkyl group, Protein/Peptide represents a protein or a peptide, Protein/Peptide A and Protein/Peptide B are optionally the same or different, L represents a linker and Z represents the reactive functional group;
- comprising:
- reacting a crosslinked protein(s) or peptide(s) represented by the following formula:
- wherein A is a hydrogen atom, a C1 to 6 alkyl group optionally substituted with a phenyl group or a halogen atom, a phenyl group, or a C1 to 6 alkyl group, Protein/Peptide represents a protein or a peptide, and Protein/Peptide A and Protein/Peptide B are optionally the same or different;
- and NH2-L-Z (L represents a linker and Z represents the reactive functional group), to thereby introduce the reactive functional group to a crosslinked portion of the crosslinked protein(s) or peptide(s).
A method for producing a complex of a protein(s) or a peptide(s) and a drug represented by the following formula:
- wherein A is a hydrogen atom, a C1 to 6 alkyl group optionally substituted with a phenyl group or a halogen atom, a phenyl group, or a C1 to 6 alkyl group, Protein/Peptide represents a protein or a peptide, Protein/Peptide A and Protein/Peptide B are optionally the same or different, L represents a linker and D represents the drug;
- comprising:
- reacting a protein(s) or a peptide(s) bound to a reactive functional group which is represented by the following formula:
- wherein A is a hydrogen atom, a C1 to 6 alkyl group optionally substituted with a phenyl group or a halogen atom, a phenyl group, or a C1 to 6 alkyl group, Protein/Peptide represents a protein or a peptide, Protein/Peptide A and Protein/Peptide B are optionally the same or different, L represents a linker and Z represents the reactive functional group;
- and the drug having another functional group reactive with the reactive functional group, to thereby bind the drug to a crosslinked portion of the crosslinked protein(s) or peptide(s).
A crosslinked protein(s) or peptide(s) represented by the following formula:
- wherein A is a hydrogen atom, a C1 to 6 alkyl group optionally substituted with a phenyl group or a halogen atom, a phenyl group, or a C1 to 6 alkyl group, Protein/Peptide represents a protein or a peptide, and Protein/Peptide A and Protein/Peptide B are optionally the same or different.
A protein(s) or a peptide(s) bound to a reactive functional group represented by the following formula:
- wherein A is a hydrogen atom, a C1 to 6 alkyl group optionally substituted with a phenyl group or a halogen atom, a phenyl group, or a C1 to 6 alkyl group, Protein/Peptide represents a protein or a peptide, Protein/Peptide A and Protein/Peptide B are optionally the same or different, L represents a linker and Z represents the reactive functional group.
A complex of a protein(s) or a peptide(s) and a drug represented by the following formula:
- wherein A is a hydrogen atom, a C1 to 6 alkyl group optionally substituted with a phenyl group or a halogen atom, a phenyl group, or a C1 to 6 alkyl group, Protein/Peptide represents a protein or a peptide, Protein/Peptide A and Protein/Peptide B are optionally the same or different, L represents a linker and D represents the drug.
A method for producing an IgG-Fc region-containing molecule bound to an Fc-binding peptide having a reactive functional group Z,
- wherein the Fc-binding peptide is represented by the following formula:
- wherein A is a hydrogen atom, a C1 to 6 alkyl group optionally substituted with a phenyl group or a halogen atom, a phenyl group, or a C1 to 6 alkyl group, L represents a linker and Z represents the reactive functional group;
- comprising
- reacting an IgG-Fc region-containing molecule bound to a crosslinked Fc-binding peptide represented by the following formula:
- wherein A is a hydrogen atom, a C1 to 6 alkyl group optionally substituted with a phenyl group or a halogen atom, a phenyl group, or a C1 to 6 alkyl group;
- and NH2-L-Z (L represents a linker and Z represents the reactive functional group), to thereby introduce the reactive functional group into a crosslinked portion in the crosslinked Fc-binding peptide.
A method for producing an IgG-Fc region-containing molecule bound to an Fc-binding peptide having a drug D,
- wherein the Fc-binding peptide is represented by the following formula:
- comprising:
- reacting an IgG-Fc region-containing molecule bound to an Fc-binding peptide(s) having a reactive functional group Z,
- wherein the Fc-binding peptide is represented by the following formula:
- wherein A is a hydrogen atom, a C1 to 6 alkyl group optionally substituted with a phenyl group or a halogen atom, a phenyl group, or a C1 to 6 alkyl group, L represents a linker and Z represents the reactive functional group;
- and the drug having another functional group reactive with the reactive functional group Z, to thereby bind the drug to a crosslinked portion of a crosslinked protein or peptide.
A method for producing a crosslinked protein or peptide in which at least two thiol groups are bound as,
- wherein the crosslinked protein or peptide is represented by the following formula:
- wherein A is a hydrogen atom, a C1 to 6 alkyl group optionally substituted with a phenyl group or a halogen atom, a phenyl group, or a C1 to 6 alkyl group, and Protein/Peptide represents a protein or a peptide;
- comprising:
- synthesizing the protein or peptide by an Fmoc method;
- and
- using a compound represented by the following formula, instead of at least one cysteine residue, in the synthesis
A method for producing a protein or a peptide bound to a reactive functional group or drug-represented by the following formula:
- wherein A is a hydrogen atom, a C1 to 6 alkyl group optionally substituted with a phenyl group or a halogen atom, a phenyl group, or a C1 to 6 alkyl group, Protein/Peptide represents a protein or a peptide, L represents a linker, Z represents the reactive functional group and D represents a drug;
- comprising:
- synthesizing the protein or peptide by an Fmoc method;
- and
- using a compound represented by the following formula, instead of at least one cysteine residue, in the synthesis
Dependencies are inferred from the claim text.